Hyugalife.com partners with Katrina Kaif to promote health and wellness in India

Our Bureau

Sequoia India’s Surge-backed health and wellness platform, Hyugalife.com, has partnered with Indian actor and fitness icon, Katrina Kaif, to promote health and wellness in India. With India’s growing prioritization of health and fitness, Hyugalife.com offers a wide range of authentic health and wellness products, including health supplements, health foods, weight management products, sports nutrition, and women’s health products. The platform sources these products directly from leading brands such as Gynoveda, MuscleBlaze, Optimum Nutrition, Oziva, Plix, and Power Gummies.

Hyugalife.com’s vision is to improve the health standards in India by offering authentic health and wellness products to the audience’s convenience by creating a one-stop marketplace. The platform’s parent company, Pratech Brands, has raised $3 million led by Sequoia India’s Surge. With Katrina Kaif’s investment in the platform, it provides a valuable opportunity for the company to reach an even wider audience. Katrina Kaif’s partnership with Hyugalife.com is a significant validation of the platform’s mission, and the team looks forward to working with her to help bring their vision of a healthier and happier India to life.

Speaking about the partnership, Katrina Kaif said, “I am a firm believer that fitness isn’t simply about working out or just having a nutritious diet, it’s a way of life. With an aim at promoting and maintaining a healthy lifestyle, Hyugalife.com is offering high-quality, authentic products at our fingertips. I look forward to working with the team to help bring their vision of a healthier & happier India to life.” Anvi Shah, CEO of Hyugalife.com, adds, “We are thrilled to have Katrina Kaif as an investor and partner in Hyugalife.com, so we together can help achieve our mission.”


Leave a Reply

Your email address will not be published. Required fields are marked *

Next Post

Eli Lilly Launches New Treatment Option for Psoriasis and Psoriatic Arthritis in India

Eli Lilly, a leading pharmaceutical company, has launched Copellor® (Ixekizumab) in India following approval from The Drug Controller General of India (DCGI). The drug is designed to treat moderate-to-severe plaque psoriasis and active psoriatic arthritis in adult patients who are candidates for systemic therapy or phototherapy. Copellor® is a humanized […]

Subscribe Now